Will my patient really benefit from chemotherapy? What is the outcome for my patient in the next 5-9 years? Should I order an Oncotype DX Breast Recurrence Score® test to better understand the underlying tumour biology of my patient’s cancer and thus be able to make a tailored chemotherapy treatment decision?
HR+, HER2-, N0/N1, early-stage breast cancer patients
The Patient Profile Navigator will provide you with N0 clinical data to help you decide whether an Oncotype DX® test would aid in making these important decisions.
With some clicks you can:
- Choose your clinical pathological parameter/s of interest
- Browse through clinical data
- Get in contact with an Exact Sciences representative